Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Pharmacology Research & Perspectives|May 3, 2023
The influence of SARS-CoV-2 infection on expression of drug-metabolizing enzymes and transporters in a hACE2 murine modelKiran Deshpande, Keith R Lange, William B Stone, et al.ACS Chemical Neuroscience|October 31, 2023
Curcumin Reduces Amyloid Beta Oligomer Interactions with Anionic MembranesChad A Sallaberry, Barbie J Voss, William B Stone, et al.Poultry Science|June 17, 2025
RESEARCH NOTE: Exploring the Competence of Various Poultry Species for Cache Valley virus InfectionKrisangel López, John A Muller, Manette Tanelus, et al.Scientific Reports|November 15, 2023
Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidateManette Tanelus, Krisangel López, Shaan Smith, et al.Emerging Microbes & Infections|August 6, 2021
Novel murine models for studying Cache Valley virus pathogenesis and <i>in utero</i> transmissionKrisangel López, Sarah N Wilson, Sheryl Coutermash-Ott, et al.Journal of Medical Virology|January 19, 2023
A hepatitis B virus core antigen-based virus-like particle vaccine expressing SARS-CoV-2 B and T cell epitopes induces epitope-specific humoral and cell-mediated immune responses but confers limited protection against SARS-CoV-2 infectionAnna M Hassebroek, Harini Sooryanarain, Connie L Heffron, et al.Frontiers in Immunology|March 17, 2022
A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in MiceLorena M Coria, Lucas M Saposnik, Celeste Pueblas Castro, et al.Biorxiv : the Preprint Server for Biology|March 30, 2023
Nanobodies against SARS-CoV-2 reduced virus load in the brain of challenged mice and neutralized Wuhan, Delta and Omicron VariantsMaría Florencia Pavan, Marina Bok, Rafael Betanzos San Juan, et al.Nature Communications|February 2, 2024
A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infectionLorena M Coria, Juan Manuel Rodriguez, Agostina Demaria, et al.Pageof 1